Answers are grounded in this paper and cite their sources.
This is the first evidence that central and peripheral CB receptors are responsible for the protective and therapeutic action of cannabinoids in mouse models of colitis. Our observations provide new insight to CB pharmacology and validate the use of novel ligands AM841 and CB13 as potent tools in CB-related research.
No takes yet. Share an insight, caveat, or question.
Fichna et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: